Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/218975| Title: | Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain |
| Author: | Cantarero, David Ocaña, Daniel Onieva-García, María Ángeles Rodríguez-García, Juan Gálvez, Paulina Méndez, Cristina Crespo Palomo, Carlos López-Ibáñez de Aldecoa, Alejandra |
| Keywords: | Vacuna antipneumocòccica Anàlisi cost-benefici Pneumococcal vaccine Cost effectiveness |
| Issue Date: | 14-Aug-2023 |
| Publisher: | Elsevier B.V. |
| Abstract: | A cost-utility analysis was conducted to assess the efficiency of implementing a PCV20 vaccination strategy in the Spanish adult population older than 60 years, for the prevention of non-bacteremic pneumococcal pneumonia (NBP) and invasive pneumococcal disease (IPD). |
| Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.vaccine.2023.07.016 |
| It is part of: | Vaccine, 2023, vol. 41, num.36, p. 5342-5349 |
| URI: | https://hdl.handle.net/2445/218975 |
| Related resource: | https://doi.org/10.1016/j.vaccine.2023.07.016 |
| ISSN: | 0264-410X |
| Appears in Collections: | Articles publicats en revistes (Genètica, Microbiologia i Estadística) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 826090.pdf | 753.46 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
